You just read:

TCR(2) Therapeutics Presents Positive Solid Tumor Data for its Novel TRuC™ Engineered T Cell Therapies at the World Preclinical Congress

News provided by

TCR2 Therapeutics

Jun 13, 2017, 09:15 ET